BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26363701)

  • 41. Cognitive behaviour therapy for older adults experiencing insomnia and depression in a community mental health setting: Study protocol for a randomised controlled trial.
    Sadler P; McLaren S; Klein B; Jenkins M; Harvey J
    Trials; 2015 Nov; 16():538. PubMed ID: 26614277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe SE; French P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TRE; Davies L; Kingdon D;
    Lancet Psychiatry; 2018 Aug; 5(8):633-643. PubMed ID: 30001930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of digital Cognitive Behavioural Therapy for Insomnia on cognitive function: study protocol for a randomised controlled trial.
    Kyle SD; Hurry MED; Emsley R; Luik AI; Omlin X; Spiegelhalder K; Espie CA; Sexton CE
    Trials; 2017 Jun; 18(1):281. PubMed ID: 28623947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of cognitive behavioural therapy and bright light therapy for insomnia in youths with eveningness: study protocol for a randomised controlled trial.
    Li SX; Cheung FTW; Chan NY; Chan JWY; Zhang J; Li AM; Espie CA; Gradisar M; Wing YK
    Trials; 2024 Apr; 25(1):246. PubMed ID: 38594725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial.
    McCurry SM; Guthrie KA; Morin CM; Woods NF; Landis CA; Ensrud KE; Larson JC; Joffe H; Cohen LS; Hunt JR; Newton KM; Otte JL; Reed SD; Sternfeld B; Tinker LF; LaCroix AZ
    JAMA Intern Med; 2016 Jul; 176(7):913-20. PubMed ID: 27213646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. D-cycloserine augmentation of cognitive behavioral therapy for delusions: A randomized clinical trial.
    Diminich ED; Dickerson F; Bello I; Cather C; Kingdon D; Rakhshan Rouhakhtar PJ; Hart KL; Li C; Troxel AB; Goff DC
    Schizophr Res; 2020 Aug; 222():145-152. PubMed ID: 32591238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Cognitive Behavioral Therapy for Insomnia on Alcohol Treatment Outcomes Among US Veterans: A Randomized Clinical Trial.
    Miller MB; Carpenter RW; Freeman LK; Dunsiger S; McGeary JE; Borsari B; McCrae CS; Arnedt JT; Korte P; Merrill JE; Carey KB; Metrik J
    JAMA Psychiatry; 2023 Sep; 80(9):905-913. PubMed ID: 37342036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial.
    Pot-Kolder RMCA; Geraets CNW; Veling W; van Beilen M; Staring ABP; Gijsman HJ; Delespaul PAEG; van der Gaag M
    Lancet Psychiatry; 2018 Mar; 5(3):217-226. PubMed ID: 29429948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
    Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review and discussion of symptom specific cognitive behavioural approaches to delusions and hallucinations.
    Lincoln TM; Peters E
    Schizophr Res; 2019 Jan; 203():66-79. PubMed ID: 29352708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive behaviour therapy for psychosis can be adapted for minority ethnic groups: a randomised controlled trial.
    Rathod S; Phiri P; Harris S; Underwood C; Thagadur M; Padmanabi U; Kingdon D
    Schizophr Res; 2013 Feb; 143(2-3):319-26. PubMed ID: 23231878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Automated psychological therapy using virtual reality (VR) for patients with persecutory delusions: study protocol for a single-blind parallel-group randomised controlled trial (THRIVE).
    Freeman D; Lister R; Waite F; Yu LM; Slater M; Dunn G; Clark D
    Trials; 2019 Jan; 20(1):87. PubMed ID: 30696471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).
    Lovell K; Bower P; Gellatly J; Byford S; Bee P; McMillan D; Arundel C; Gilbody S; Gega L; Hardy G; Reynolds S; Barkham M; Mottram P; Lidbetter N; Pedley R; Molle J; Peckham E; Knopp-Hoffer J; Price O; Connell J; Heslin M; Foley C; Plummer F; Roberts C
    Health Technol Assess; 2017 Jun; 21(37):1-132. PubMed ID: 28681717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic (Sleep COVID-19): structured summary of a study protocol for a randomised controlled trial.
    Elder GJ; Alfonso-Miller P; Atkinson WCM; Santhi N; Ellis JG
    Trials; 2020 Aug; 21(1):704. PubMed ID: 32771068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
    Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive behavioural therapy for post-stroke fatigue and sleep disturbance: a pilot randomised controlled trial with blind assessment.
    Nguyen S; Wong D; McKay A; Rajaratnam SMW; Spitz G; Williams G; Mansfield D; Ponsford JL
    Neuropsychol Rehabil; 2019 Jun; 29(5):723-738. PubMed ID: 28521579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.
    O'Dowd H; Gladwell P; Rogers CA; Hollinghurst S; Gregory A
    Health Technol Assess; 2006 Oct; 10(37):iii-iv, ix-x, 1-121. PubMed ID: 17014748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial.
    Wiles NJ; Thomas L; Turner N; Garfield K; Kounali D; Campbell J; Kessler D; Kuyken W; Lewis G; Morrison J; Williams C; Peters TJ; Hollinghurst S
    Lancet Psychiatry; 2016 Feb; 3(2):137-44. PubMed ID: 26777773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: a meta-analysis.
    van der Gaag M; Valmaggia LR; Smit F
    Schizophr Res; 2014 Jun; 156(1):30-7. PubMed ID: 24731619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving perinatal sleep via a scalable cognitive behavioural intervention: findings from a randomised controlled trial from pregnancy to 2 years postpartum.
    Bei B; Pinnington DM; Quin N; Shen L; Blumfield M; Wiley JF; Drummond SPA; Newman LK; Manber R
    Psychol Med; 2023 Jan; 53(2):513-523. PubMed ID: 34231450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.